Search for: "Novartis Ag" Results 321 - 340 of 440
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 May 2010, 10:18 am
A jury has ordered a Novartis AG pharmaceuticals unit to pay $3.4 million to a dozen women in a gender bias lawsuit. [read post]
21 May 2010, 7:38 am by Ms. JD Weekly Roundup
Image:  ms_jd_weekly_round-up.jpg SDNY Judge Barbara Jones - Who Also Presided Over the WorldCom Criminal Proceedings - Is Assigned Goldman Sach's Civil Fraud Case Goodwin Liu's Nomination Draws Attention to the Under-Representation of Asian American's on the Federal Judicial (10 out of 875) Kagan as a Representastive of the Generation that Could Not "Have It All" The Pitfalls of Domestic Micro-Managing, i.e. the… [read post]
19 May 2010, 2:17 pm
Reuters is reporting that a New York jury has awarded $250 million in punitive damages against drugmaker Novartis AG in an employment discrimination class action.The Reuters story says that the jury awarded $3.3 million in compensatory damages to 12 of the plaintiffs, but compensatory damages have not yet been determined for the other 5,588 women in the class.The availability of punitive damages in class actions is a hot topic in punitive damages litigation. [read post]
19 May 2010, 8:23 am
 A federal jury on Monday found that the U.S. unit of Swiss drug maker Novartis AG engaged in a "pattern or practice" of discrimination against its female employees. [read post]
10 May 2010, 9:34 pm by Patent Docs
By James DeGiulio -- Celgene and Novartis Reach Settlement with Barr Laboratories in Ritalin ANDA Suit Celgene Corp. and Novartis AG have reached a settlement with Barr Laboratories Inc. over Barr's attempt to market a generic version of the ADHD drug Ritalin. [read post]
10 May 2010, 8:16 am by Dan Irving Cytryn, Esq.
The study researched records of over 297,000 patients who took anticonvulsants between 2001 and 2006 and were 15 years of age or older. [read post]
5 May 2010, 5:14 pm by FDABlog HPM
  To add insult to injury, DDMAC determined that the Avantix website, www.bloodleveltesting.com, was registered to Novartis, its content referred to Novartis, and it contained logos for and links to the CML and GIST Alliances. [read post]
22 Apr 2010, 3:51 am
(Patent Docs) Bystolic (Nebivolol) – Austrian Supreme Court on limitation of patent claims: Case no 17 Ob 24/09t (EPLAW) Denegard / Milbemite / Ocupress - US: District Court W D Tennessee: False marking complaint: Baker v Novartis Pharmaceuticals et al (Patent Docs) Felbatol (Felbamate) – US: CAFC affirms District Court decision enforcing settlement agreement regarding the transfer of patent ownership: MedPointe Healthcare, Inc v Kozachuk (not precedential) (Patent Docs) Husar… [read post]
19 Mar 2010, 6:25 am by Simon Fodden
WOW, all by itself, has been approved as a trade-mark of, among others, Novartis AG veterinary preparations, Playtex in connection with “ladies’ underwear and foundation garments”, and for a wave-making machine by Servilog S.A., a Belgian company, none of which are likely to be confused with banking services. [read post]
19 Mar 2010, 4:13 am by Mark Zamora
The FDA is considering expanding the warning labels of the Novartis AG cream Elidel (pimecrolimus) and AStellas Pharma’s Protopic (tacrolimus) used to treat eczema. [read post]
18 Mar 2010, 2:30 am
The case of generic Flomax – Hatch-Waxman backstory to approval of Impax first generic version of Boehringer Ingelheim’s Flomax (FDA Law Blog) Focalin (Dexmethylphenidate), Ritalin (Methylphenidate) - US: Settlement in ADHD patent infringement suits announced - Celgene Corp. and Novartis AG against defendants KV Pharmaceutical Co. and IntelliPharmaCeutics Corp (Patent Docs) (GenericsWeb) Neupogen (Filgrastim) – US: District Court N D Illinois: False marking… [read post]
16 Mar 2010, 1:55 pm by Tom Lamb
Includes A New "Black Box" Warning About Renal Impairment, Liver Failure, And Gastrointestinal Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-February 2010 the FDA and Novartis announced a change to the Prescribing Information (PI) -- also referred to as the package insert or label -- for Exjade (deferasirox), a drug indicated for the treatment of chronic iron overload due to blood transfusions in patients two years of age and older. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
26 Feb 2010, 2:40 pm by Josh
., a subsidiary of Swiss drug giant Novartis AG, misrepresented the regulatory status of its drug  Nitroglycerin SR and failed to advise the government that the drug did not qualify for Medicaid coverage. [read post]
24 Feb 2010, 10:14 am by fraudfighters
(a subsidiary of Novartis AG) to resolve a False Claims Act lawsuit alleging that the company had submitted false claims to Medicaid in connection with its drug Nitroglycerin Sustained Release (SR) capsules. [read post]
23 Feb 2010, 11:48 am by admin
., a subsidiary of Swiss company Novartis AG, submitted false reports to the government between April 1999 and September 2008 that misrepresented Nitroglycerin SR’s regulatory status and failed to advise that the drug did not qualify for Medicaid coverage. [read post]